Rank | Gene Set | Z-score |
---|---|---|
1 | skeletal muscle adaptation (GO:0043501) | 9.56172327 |
2 | skeletal muscle fiber development (GO:0048741) | 7.80574087 |
3 | actin filament-based movement (GO:0030048) | 7.66665699 |
4 | plasma membrane repair (GO:0001778) | 7.61658773 |
5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.16840984 |
6 | sarcomere organization (GO:0045214) | 6.85076156 |
7 | striated muscle contraction (GO:0006941) | 6.64820508 |
8 | myotube cell development (GO:0014904) | 6.63657600 |
9 | creatine metabolic process (GO:0006600) | 6.50740875 |
10 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.49536567 |
11 | glycogen catabolic process (GO:0005980) | 6.43114176 |
12 | skeletal muscle tissue regeneration (GO:0043403) | 6.17881729 |
13 | myofibril assembly (GO:0030239) | 6.11413906 |
14 | carnitine shuttle (GO:0006853) | 6.05848474 |
15 | glucan catabolic process (GO:0009251) | 6.02093981 |
16 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.94281499 |
17 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.77989273 |
18 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.77640774 |
19 | purine nucleotide salvage (GO:0032261) | 5.73288196 |
20 | response to muscle activity (GO:0014850) | 5.64118924 |
21 | regulation of cell communication by electrical coupling (GO:0010649) | 5.62596709 |
22 | cytidine deamination (GO:0009972) | 5.62561299 |
23 | cytidine metabolic process (GO:0046087) | 5.62561299 |
24 | cytidine catabolic process (GO:0006216) | 5.62561299 |
25 | striated muscle atrophy (GO:0014891) | 5.61787640 |
26 | cellular polysaccharide catabolic process (GO:0044247) | 5.58129151 |
27 | polysaccharide catabolic process (GO:0000272) | 5.46585146 |
28 | response to inactivity (GO:0014854) | 5.45849019 |
29 | * muscle contraction (GO:0006936) | 5.33980583 |
30 | glycogen biosynthetic process (GO:0005978) | 5.19188282 |
31 | glucan biosynthetic process (GO:0009250) | 5.19188282 |
32 | striated muscle adaptation (GO:0014888) | 5.11679374 |
33 | fatty acid transmembrane transport (GO:1902001) | 5.10594159 |
34 | NADH metabolic process (GO:0006734) | 5.07304160 |
35 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.99526746 |
36 | muscle fiber development (GO:0048747) | 4.87368052 |
37 | muscle atrophy (GO:0014889) | 4.86059135 |
38 | IMP metabolic process (GO:0046040) | 4.79950666 |
39 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.76894165 |
40 | * muscle system process (GO:0003012) | 4.75606542 |
41 | actomyosin structure organization (GO:0031032) | 4.71303607 |
42 | fructose metabolic process (GO:0006000) | 4.64467717 |
43 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.60542737 |
44 | carnitine transmembrane transport (GO:1902603) | 4.59977900 |
45 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.56400891 |
46 | cardiac muscle hypertrophy (GO:0003300) | 4.46288618 |
47 | glycogen metabolic process (GO:0005977) | 4.42166213 |
48 | muscle organ morphogenesis (GO:0048644) | 4.41991926 |
49 | glucan metabolic process (GO:0044042) | 4.33302010 |
50 | cellular glucan metabolic process (GO:0006073) | 4.33302010 |
51 | striated muscle hypertrophy (GO:0014897) | 4.26180637 |
52 | amino-acid betaine transport (GO:0015838) | 4.19635582 |
53 | carnitine transport (GO:0015879) | 4.19635582 |
54 | gluconeogenesis (GO:0006094) | 4.17995893 |
55 | regulation of relaxation of muscle (GO:1901077) | 4.13939420 |
56 | muscle adaptation (GO:0043500) | 4.13868850 |
57 | cardiac muscle contraction (GO:0060048) | 4.13355023 |
58 | regulation of coenzyme metabolic process (GO:0051196) | 4.08833163 |
59 | regulation of cofactor metabolic process (GO:0051193) | 4.08833163 |
60 | muscle cell fate commitment (GO:0042693) | 4.05965313 |
61 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.94450466 |
62 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.91686052 |
63 | response to activity (GO:0014823) | 3.89916131 |
64 | negative regulation of muscle hypertrophy (GO:0014741) | 3.86454751 |
65 | neuronal action potential propagation (GO:0019227) | 3.86047217 |
66 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.85327097 |
67 | tricarboxylic acid cycle (GO:0006099) | 3.82332483 |
68 | muscle tissue morphogenesis (GO:0060415) | 3.81360500 |
69 | muscle hypertrophy (GO:0014896) | 3.81084021 |
70 | muscle organ development (GO:0007517) | 3.76805476 |
71 | striated muscle cell development (GO:0055002) | 3.76721606 |
72 | hexose biosynthetic process (GO:0019319) | 3.74481303 |
73 | muscle structure development (GO:0061061) | 3.74305429 |
74 | muscle cell cellular homeostasis (GO:0046716) | 3.68251186 |
75 | heart contraction (GO:0060047) | 3.68076256 |
76 | heart process (GO:0003015) | 3.68076256 |
77 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.67133233 |
78 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.66825596 |
79 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.66825596 |
80 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.66806625 |
81 | cardiac myofibril assembly (GO:0055003) | 3.61435718 |
82 | ubiquinone biosynthetic process (GO:0006744) | 3.61370577 |
83 | adult heart development (GO:0007512) | 3.60796167 |
84 | cellular response to dexamethasone stimulus (GO:0071549) | 3.60287303 |
85 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.57079409 |
86 | cellular carbohydrate catabolic process (GO:0044275) | 3.56487150 |
87 | IMP biosynthetic process (GO:0006188) | 3.56168708 |
88 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.53790994 |
89 | negative regulation of muscle contraction (GO:0045932) | 3.50289519 |
90 | regulation of actin filament-based movement (GO:1903115) | 3.46576558 |
91 | skeletal muscle tissue development (GO:0007519) | 3.43510672 |
92 | regulation of striated muscle contraction (GO:0006942) | 3.39222731 |
93 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.38320338 |
94 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.38320338 |
95 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.37227787 |
96 | muscle hypertrophy in response to stress (GO:0003299) | 3.37227787 |
97 | cardiac muscle adaptation (GO:0014887) | 3.37227787 |
98 | neuromuscular synaptic transmission (GO:0007274) | 3.36922629 |
99 | response to dexamethasone (GO:0071548) | 3.35853038 |
100 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.35671221 |
101 | regulation of sulfur metabolic process (GO:0042762) | 3.34296786 |
102 | striated muscle tissue development (GO:0014706) | 3.32970365 |
103 | AMP metabolic process (GO:0046033) | 3.30525538 |
104 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.29672896 |
105 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.26321586 |
106 | regulation of myoblast differentiation (GO:0045661) | 3.25893952 |
107 | myotube differentiation (GO:0014902) | 3.25498171 |
108 | positive regulation of myotube differentiation (GO:0010831) | 3.25051736 |
109 | positive regulation of cation channel activity (GO:2001259) | 3.22558710 |
110 | relaxation of muscle (GO:0090075) | 3.21812219 |
111 | cardiac muscle cell development (GO:0055013) | 3.21135141 |
112 | succinate metabolic process (GO:0006105) | 3.20720161 |
113 | muscle cell development (GO:0055001) | 3.20572993 |
114 | intracellular lipid transport (GO:0032365) | 3.19421508 |
115 | regulation of sequestering of triglyceride (GO:0010889) | 3.18867126 |
116 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.18857098 |
117 | ubiquinone metabolic process (GO:0006743) | 3.18451273 |
118 | 2-oxoglutarate metabolic process (GO:0006103) | 3.13809322 |
119 | myoblast fusion (GO:0007520) | 3.12638289 |
120 | cellular polysaccharide metabolic process (GO:0044264) | 3.07848541 |
121 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.06004383 |
122 | polysaccharide biosynthetic process (GO:0000271) | 3.01482147 |
123 | muscle filament sliding (GO:0030049) | 12.5602837 |
124 | actin-myosin filament sliding (GO:0033275) | 12.5602837 |
125 | regulation of skeletal muscle contraction (GO:0014819) | 12.1030958 |
126 | skeletal muscle contraction (GO:0003009) | 10.8777406 |
127 | actin-mediated cell contraction (GO:0070252) | 10.2810904 |
128 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.2113163 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.49832093 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.88329905 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.79709723 |
4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.66049228 |
5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.41461316 |
6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.34415480 |
7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.30764208 |
8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.07263373 |
9 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.75449373 |
10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.72386669 |
11 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.64834222 |
12 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.64834222 |
13 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.35293766 |
14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.33408362 |
15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.32113288 |
16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.23792736 |
17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.12391214 |
18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.03269859 |
19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.93298428 |
20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89030961 |
21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.84348680 |
22 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.80605236 |
23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.78040324 |
24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.78018805 |
25 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.76960778 |
26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.75973068 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75215667 |
28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.71362240 |
29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.65014651 |
30 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.63172680 |
31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.62178705 |
32 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.56424384 |
33 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.52869042 |
34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52453869 |
35 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.50476759 |
36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47934835 |
37 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.47046438 |
38 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.47018061 |
39 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.44344268 |
40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41022384 |
41 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.36870386 |
42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34580693 |
43 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.34555144 |
44 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30634890 |
45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23854560 |
46 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.22804779 |
47 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.21542569 |
48 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21356664 |
49 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.20805329 |
50 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.19861068 |
51 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.17505265 |
52 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.17062917 |
53 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16983809 |
54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15404715 |
55 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.13807430 |
56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13689676 |
57 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.12944250 |
58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11631070 |
59 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10327838 |
60 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.09815704 |
61 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08634316 |
62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08448115 |
63 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.07890295 |
64 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.07801890 |
65 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07227129 |
66 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.07211474 |
67 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07059000 |
68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06136892 |
69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05310804 |
70 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.04868620 |
71 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04305137 |
72 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03687415 |
73 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03319871 |
74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03072597 |
75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03072597 |
76 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02875540 |
77 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02452514 |
78 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02446965 |
79 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01276287 |
80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01261736 |
81 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01149371 |
82 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00175834 |
83 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.99393787 |
84 | CJUN_26792858_Chip-Seq_BT549_Human | 0.98600640 |
85 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.98122968 |
86 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97704074 |
87 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97594799 |
88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97106595 |
89 | P68_20966046_ChIP-Seq_HELA_Human | 0.96321607 |
90 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95022399 |
91 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94422261 |
92 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94367883 |
93 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93791240 |
94 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92722154 |
95 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92529931 |
96 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.92330941 |
97 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.92192483 |
98 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91282206 |
99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91160955 |
100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.90764449 |
101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.90604477 |
102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90148514 |
103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90090606 |
104 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90019685 |
105 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.89663150 |
106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88625567 |
107 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87727443 |
108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87557024 |
109 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.87216566 |
110 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84902131 |
111 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.84665242 |
112 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84571986 |
113 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.84411042 |
114 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83450531 |
115 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.83139217 |
116 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.82786982 |
117 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82510773 |
118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81315479 |
119 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81201841 |
120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80574870 |
121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80574870 |
122 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.79503079 |
123 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.79320546 |
124 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.78976433 |
125 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.78865917 |
126 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.78857449 |
127 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.78791681 |
128 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78756917 |
129 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.78737585 |
130 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.78676375 |
131 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78601240 |
132 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78036322 |
133 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.75589661 |
134 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.74812065 |
135 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.73224788 |
136 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.72215630 |
137 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.71018576 |
138 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.70757848 |
139 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.69516426 |
140 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.68992000 |
141 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.68875743 |
142 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.66351706 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004145_abnormal_muscle_electrophysio | 7.81614442 |
2 | MP0003646_muscle_fatigue | 6.49057336 |
3 | MP0000749_muscle_degeneration | 6.30788303 |
4 | MP0000751_myopathy | 5.57961340 |
5 | MP0000747_muscle_weakness | 4.33716128 |
6 | MP0002106_abnormal_muscle_physiology | 4.15876389 |
7 | MP0004036_abnormal_muscle_relaxation | 4.09996553 |
8 | MP0002837_dystrophic_cardiac_calcinosis | 3.85868194 |
9 | MP0000759_abnormal_skeletal_muscle | 3.75460177 |
10 | MP0002269_muscular_atrophy | 3.53009738 |
11 | MP0005369_muscle_phenotype | 3.46839206 |
12 | MP0004087_abnormal_muscle_fiber | 3.42730910 |
13 | MP0004130_abnormal_muscle_cell | 3.37246836 |
14 | MP0000750_abnormal_muscle_regeneration | 3.30713896 |
15 | MP0005620_abnormal_muscle_contractility | 3.18249476 |
16 | MP0004233_abnormal_muscle_weight | 2.53311828 |
17 | MP0002332_abnormal_exercise_endurance | 2.25690183 |
18 | MP0000733_abnormal_muscle_development | 2.20925637 |
19 | MP0005330_cardiomyopathy | 2.14790612 |
20 | MP0002108_abnormal_muscle_morphology | 1.97983520 |
21 | MP0006036_abnormal_mitochondrial_physio | 1.94834678 |
22 | MP0004084_abnormal_cardiac_muscle | 1.88729374 |
23 | MP0004185_abnormal_adipocyte_glucose | 1.74827549 |
24 | MP0004215_abnormal_myocardial_fiber | 1.60897074 |
25 | MP0004484_altered_response_of | 1.46296927 |
26 | MP0002972_abnormal_cardiac_muscle | 1.45037881 |
27 | MP0005666_abnormal_adipose_tissue | 1.42171605 |
28 | MP0010630_abnormal_cardiac_muscle | 1.31113199 |
29 | MP0002971_abnormal_brown_adipose | 1.29888639 |
30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.24683552 |
31 | MP0003806_abnormal_nucleotide_metabolis | 1.15468865 |
32 | MP0005385_cardiovascular_system_phenoty | 1.06775737 |
33 | MP0001544_abnormal_cardiovascular_syste | 1.06775737 |
34 | MP0002822_catalepsy | 1.04444447 |
35 | MP0005375_adipose_tissue_phenotype | 1.03022810 |
36 | MP0005266_abnormal_metabolism | 1.02623130 |
37 | MP0004270_analgesia | 1.00339190 |
38 | MP0006035_abnormal_mitochondrial_morpho | 0.99749102 |
39 | MP0001661_extended_life_span | 0.98669012 |
40 | MP0000383_abnormal_hair_follicle | 0.94532351 |
41 | MP0000013_abnormal_adipose_tissue | 0.92359026 |
42 | MP0003137_abnormal_impulse_conducting | 0.90328793 |
43 | MP0003950_abnormal_plasma_membrane | 0.89766438 |
44 | MP0004147_increased_porphyrin_level | 0.88193039 |
45 | MP0000372_irregular_coat_pigmentation | 0.84807031 |
46 | MP0005275_abnormal_skin_tensile | 0.82269609 |
47 | MP0002234_abnormal_pharynx_morphology | 0.78980084 |
48 | MP0003705_abnormal_hypodermis_morpholog | 0.77372290 |
49 | MP0004043_abnormal_pH_regulation | 0.75698326 |
50 | MP0004134_abnormal_chest_morphology | 0.75524143 |
51 | MP0003656_abnormal_erythrocyte_physiolo | 0.74707254 |
52 | MP0008775_abnormal_heart_ventricle | 0.74013750 |
53 | MP0000762_abnormal_tongue_morphology | 0.71881248 |
54 | MP0009250_abnormal_appendicular_skeleto | 0.70696756 |
55 | MP0009780_abnormal_chondrocyte_physiolo | 0.68565626 |
56 | MP0002796_impaired_skin_barrier | 0.68247971 |
57 | MP0002127_abnormal_cardiovascular_syste | 0.64738819 |
58 | MP0008961_abnormal_basal_metabolism | 0.62358698 |
59 | MP0010678_abnormal_skin_adnexa | 0.60515261 |
60 | MP0005334_abnormal_fat_pad | 0.59650273 |
61 | MP0002078_abnormal_glucose_homeostasis | 0.57505320 |
62 | MP0003879_abnormal_hair_cell | 0.57474959 |
63 | MP0000343_altered_response_to | 0.57234347 |
64 | MP0003828_pulmonary_edema | 0.56587966 |
65 | MP0000266_abnormal_heart_morphology | 0.55497541 |
66 | MP0001299_abnormal_eye_distance/ | 0.54475780 |
67 | MP0000003_abnormal_adipose_tissue | 0.52723216 |
68 | MP0006138_congestive_heart_failure | 0.52236121 |
69 | MP0005670_abnormal_white_adipose | 0.48344168 |
70 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.43616250 |
71 | MP0005083_abnormal_biliary_tract | 0.43563585 |
72 | MP0002638_abnormal_pupillary_reflex | 0.42559165 |
73 | MP0005167_abnormal_blood-brain_barrier | 0.41290539 |
74 | MP0000579_abnormal_nail_morphology | 0.41094584 |
75 | MP0004085_abnormal_heartbeat | 0.40975014 |
76 | MP0005319_abnormal_enzyme/_coenzyme | 0.40271892 |
77 | MP0010030_abnormal_orbit_morphology | 0.39333084 |
78 | MP0005535_abnormal_body_temperature | 0.38652505 |
79 | MP0003045_fibrosis | 0.38532956 |
80 | MP0005166_decreased_susceptibility_to | 0.36910724 |
81 | MP0000230_abnormal_systemic_arterial | 0.35754440 |
82 | MP0001853_heart_inflammation | 0.35707669 |
83 | MP0002896_abnormal_bone_mineralization | 0.35443370 |
84 | MP0005452_abnormal_adipose_tissue | 0.34781571 |
85 | MP0005332_abnormal_amino_acid | 0.32535951 |
86 | MP0003959_abnormal_lean_body | 0.32418301 |
87 | MP0004510_myositis | 0.30492424 |
88 | MP0005423_abnormal_somatic_nervous | 0.30223718 |
89 | MP0003567_abnormal_fetal_cardiomyocyte | 0.29125107 |
90 | MP0002060_abnormal_skin_morphology | 0.29081273 |
91 | MP0002734_abnormal_mechanical_nocicepti | 0.28631457 |
92 | MP0008569_lethality_at_weaning | 0.28469314 |
93 | MP0001243_abnormal_dermal_layer | 0.28428209 |
94 | MP0002114_abnormal_axial_skeleton | 0.27452230 |
95 | MP0009672_abnormal_birth_weight | 0.26890584 |
96 | MP0001346_abnormal_lacrimal_gland | 0.26320865 |
97 | MP0004381_abnormal_hair_follicle | 0.25869257 |
98 | MP0003948_abnormal_gas_homeostasis | 0.25437686 |
99 | MP0009115_abnormal_fat_cell | 0.25265624 |
100 | MP0005165_increased_susceptibility_to | 0.25187214 |
101 | MP0003195_calcinosis | 0.24199230 |
102 | MP0002118_abnormal_lipid_homeostasis | 0.23578684 |
103 | MP0001849_ear_inflammation | 0.23556507 |
104 | MP0005376_homeostasis/metabolism_phenot | 0.23397517 |
105 | MP0005187_abnormal_penis_morphology | 0.22870296 |
106 | MP0000377_abnormal_hair_follicle | 0.22706548 |
107 | MP0002089_abnormal_postnatal_growth/wei | 0.22604582 |
108 | MP0002066_abnormal_motor_capabilities/c | 0.22329004 |
109 | MP0001943_abnormal_respiration | 0.22322033 |
110 | MP0010234_abnormal_vibrissa_follicle | 0.22133537 |
111 | MP0002128_abnormal_blood_circulation | 0.21818242 |
112 | MP0004142_abnormal_muscle_tone | 0.21505459 |
113 | MP0005501_abnormal_skin_physiology | 0.21278048 |
114 | MP0005451_abnormal_body_composition | 0.20743123 |
115 | MP0004858_abnormal_nervous_system | 0.17404421 |
116 | MP0002876_abnormal_thyroid_physiology | 0.16567352 |
117 | MP0002067_abnormal_sensory_capabilities | 0.16231274 |
118 | MP0005645_abnormal_hypothalamus_physiol | 0.14528088 |
119 | MP0008874_decreased_physiological_sensi | 0.13819246 |
120 | MP0005386_behavior/neurological_phenoty | 0.12673714 |
121 | MP0004924_abnormal_behavior | 0.12673714 |
122 | MP0006276_abnormal_autonomic_nervous | 0.12150060 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber inclusion bodies (HP:0100299) | 9.93867873 |
2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.46199028 |
3 | Nemaline bodies (HP:0003798) | 8.93001385 |
4 | Exercise-induced myalgia (HP:0003738) | 8.78081223 |
5 | Exercise-induced muscle cramps (HP:0003710) | 7.98495035 |
6 | Type 1 muscle fiber predominance (HP:0003803) | 7.28229484 |
7 | Distal arthrogryposis (HP:0005684) | 7.11744656 |
8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.11093669 |
9 | Myopathic facies (HP:0002058) | 6.64645147 |
10 | Calf muscle hypertrophy (HP:0008981) | 6.33472292 |
11 | Round ear (HP:0100830) | 6.12425855 |
12 | Ulnar deviation of the wrist (HP:0003049) | 5.92991543 |
13 | Difficulty running (HP:0009046) | 5.44910766 |
14 | Myoglobinuria (HP:0002913) | 5.31799633 |
15 | Muscle fiber splitting (HP:0003555) | 5.18746930 |
16 | Calcaneovalgus deformity (HP:0001848) | 5.13089432 |
17 | Hyporeflexia of lower limbs (HP:0002600) | 4.99223762 |
18 | Absent phalangeal crease (HP:0006109) | 4.84244122 |
19 | Muscle stiffness (HP:0003552) | 4.83566032 |
20 | Deformed tarsal bones (HP:0008119) | 4.68371668 |
21 | EMG: myopathic abnormalities (HP:0003458) | 4.57237159 |
22 | Rhabdomyolysis (HP:0003201) | 4.46632843 |
23 | Increased connective tissue (HP:0009025) | 4.40371873 |
24 | Abnormality of the calf musculature (HP:0001430) | 4.21136418 |
25 | Myotonia (HP:0002486) | 4.14667230 |
26 | Abnormal finger flexion creases (HP:0006143) | 4.03800545 |
27 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.79555646 |
28 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.74246278 |
29 | Subaortic stenosis (HP:0001682) | 3.74246278 |
30 | Malignant hyperthermia (HP:0002047) | 3.54883797 |
31 | Neck muscle weakness (HP:0000467) | 3.50199731 |
32 | Rimmed vacuoles (HP:0003805) | 3.45417579 |
33 | Increased variability in muscle fiber diameter (HP:0003557) | 3.35717222 |
34 | Difficulty climbing stairs (HP:0003551) | 3.33314706 |
35 | Areflexia of lower limbs (HP:0002522) | 3.32404541 |
36 | Pelvic girdle muscle weakness (HP:0003749) | 3.12421662 |
37 | Frequent falls (HP:0002359) | 3.11578424 |
38 | Shoulder girdle muscle weakness (HP:0003547) | 3.10552007 |
39 | Abnormality of the calcaneus (HP:0008364) | 3.04795736 |
40 | Asymmetric septal hypertrophy (HP:0001670) | 3.03125548 |
41 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.02944113 |
42 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.02944113 |
43 | Sudden death (HP:0001699) | 2.95883203 |
44 | Hyperkalemia (HP:0002153) | 2.95293211 |
45 | Bundle branch block (HP:0011710) | 2.77163141 |
46 | Distal lower limb muscle weakness (HP:0009053) | 2.72825011 |
47 | Fatigable weakness (HP:0003473) | 2.64270320 |
48 | Abnormality of the neuromuscular junction (HP:0003398) | 2.64270320 |
49 | Paralysis (HP:0003470) | 2.53685504 |
50 | EMG: neuropathic changes (HP:0003445) | 2.53105411 |
51 | Slender build (HP:0001533) | 2.50756116 |
52 | Muscular dystrophy (HP:0003560) | 2.36799297 |
53 | Proximal amyotrophy (HP:0007126) | 2.29987401 |
54 | Hypoplastic ischia (HP:0003175) | 2.21805124 |
55 | Ventricular tachycardia (HP:0004756) | 2.21585839 |
56 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.21162925 |
57 | Limb-girdle muscle weakness (HP:0003325) | 2.19454008 |
58 | Generalized muscle weakness (HP:0003324) | 2.18269466 |
59 | Facial diplegia (HP:0001349) | 2.17668273 |
60 | Bulbar palsy (HP:0001283) | 2.14494566 |
61 | Progressive muscle weakness (HP:0003323) | 2.13952935 |
62 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.09534697 |
63 | Scapular winging (HP:0003691) | 2.04627944 |
64 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.03797346 |
65 | Nonprogressive disorder (HP:0003680) | 2.03660179 |
66 | Ulnar deviation of finger (HP:0009465) | 2.02415747 |
67 | Weak cry (HP:0001612) | 2.01911812 |
68 | Limb-girdle muscle atrophy (HP:0003797) | 2.01844705 |
69 | Spinal rigidity (HP:0003306) | 2.01515470 |
70 | Distal lower limb amyotrophy (HP:0008944) | 2.00169631 |
71 | Gowers sign (HP:0003391) | 1.99259420 |
72 | Abnormality of the foot musculature (HP:0001436) | 1.93066753 |
73 | Abnormality of the ischium (HP:0003174) | 1.93057256 |
74 | Metatarsus adductus (HP:0001840) | 1.88883876 |
75 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.85688808 |
76 | Ragged-red muscle fibers (HP:0003200) | 1.83401254 |
77 | Achilles tendon contracture (HP:0001771) | 1.82516576 |
78 | Heart block (HP:0012722) | 1.81506910 |
79 | Foot dorsiflexor weakness (HP:0009027) | 1.76935308 |
80 | Long clavicles (HP:0000890) | 1.74530007 |
81 | Lipoatrophy (HP:0100578) | 1.70609939 |
82 | Abnormal atrioventricular conduction (HP:0005150) | 1.69491750 |
83 | Waddling gait (HP:0002515) | 1.68639607 |
84 | Increased intramyocellular lipid droplets (HP:0012240) | 1.68102639 |
85 | Abnormality of the Achilles tendon (HP:0005109) | 1.66162858 |
86 | Dilated cardiomyopathy (HP:0001644) | 1.64054359 |
87 | Popliteal pterygium (HP:0009756) | 1.63167345 |
88 | Hip contracture (HP:0003273) | 1.61741682 |
89 | Fetal akinesia sequence (HP:0001989) | 1.60368547 |
90 | Tarsal synostosis (HP:0008368) | 1.58606770 |
91 | Cholelithiasis (HP:0001081) | 1.58346675 |
92 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.57882102 |
93 | Increased density of long bones (HP:0006392) | 1.56974909 |
94 | Increased muscle lipid content (HP:0009058) | 1.55905358 |
95 | Type 2 muscle fiber atrophy (HP:0003554) | 1.54419103 |
96 | Short palpebral fissure (HP:0012745) | 1.54296326 |
97 | Hyperuricemia (HP:0002149) | 1.54072321 |
98 | Increased purine levels (HP:0004368) | 1.54072321 |
99 | Abnormality of potassium homeostasis (HP:0011042) | 1.50457473 |
100 | Stridor (HP:0010307) | 1.49233938 |
101 | Exercise intolerance (HP:0003546) | 1.48889909 |
102 | Ventricular arrhythmia (HP:0004308) | 1.48759877 |
103 | Gout (HP:0001997) | 1.46302748 |
104 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.44284996 |
105 | Muscle fiber atrophy (HP:0100295) | 1.44281888 |
106 | Lower limb amyotrophy (HP:0007210) | 1.44135288 |
107 | Toxemia of pregnancy (HP:0100603) | 1.42421449 |
108 | Oligomenorrhea (HP:0000876) | 1.41693270 |
109 | Synostosis involving bones of the feet (HP:0009140) | 1.40791216 |
110 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.40791216 |
111 | Abnormal gallbladder morphology (HP:0012437) | 1.38740065 |
112 | Limited hip movement (HP:0008800) | 1.38660590 |
113 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.35886251 |
114 | Adducted thumb (HP:0001181) | 1.35620098 |
115 | Congenital hip dislocation (HP:0001374) | 1.29431812 |
116 | Steppage gait (HP:0003376) | 1.24063317 |
117 | Amniotic constriction ring (HP:0009775) | 1.21608606 |
118 | Abnormality of placental membranes (HP:0011409) | 1.21608606 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 8.62000282 |
2 | TTN | 6.57835394 |
3 | PHKG1 | 5.41587790 |
4 | PHKG2 | 5.41587790 |
5 | NME1 | 4.33449570 |
6 | PIK3CG | 3.56488207 |
7 | MAP2K3 | 3.00277582 |
8 | MAP3K7 | 2.17779044 |
9 | PINK1 | 2.13884186 |
10 | NEK1 | 2.12997646 |
11 | PDK4 | 1.99253589 |
12 | PDK3 | 1.99253589 |
13 | DMPK | 1.88404959 |
14 | TRIB3 | 1.72015566 |
15 | PIK3CA | 1.70299045 |
16 | MAPK12 | 1.66455806 |
17 | BCKDK | 1.64535674 |
18 | MAP2K4 | 1.61237023 |
19 | MAP2K6 | 1.43999819 |
20 | MUSK | 1.34738427 |
21 | PDK2 | 1.34715645 |
22 | MAP3K3 | 1.10702521 |
23 | MAPKAPK3 | 1.06447727 |
24 | STK24 | 0.96128665 |
25 | TRPM7 | 0.91452629 |
26 | PRKAA2 | 0.91369026 |
27 | MARK1 | 0.90634313 |
28 | CCNB1 | 0.90618233 |
29 | PRKAA1 | 0.81456286 |
30 | NEK9 | 0.80297873 |
31 | ERBB3 | 0.80198929 |
32 | MAP3K13 | 0.69335961 |
33 | PKN2 | 0.68933063 |
34 | TAOK2 | 0.65681280 |
35 | ZAK | 0.64537397 |
36 | MAPK11 | 0.60467796 |
37 | CAMK4 | 0.58928815 |
38 | AKT2 | 0.52655676 |
39 | CAMK2G | 0.51851781 |
40 | MAP3K1 | 0.50363398 |
41 | EEF2K | 0.49534651 |
42 | TAOK1 | 0.47465226 |
43 | ILK | 0.46933964 |
44 | MAP3K11 | 0.45816332 |
45 | SIK1 | 0.45119422 |
46 | EPHB1 | 0.44897971 |
47 | CAMK1 | 0.41927692 |
48 | RIPK1 | 0.40653055 |
49 | PTK6 | 0.40615227 |
50 | CAMK2B | 0.38512053 |
51 | MAP3K6 | 0.37569709 |
52 | TBK1 | 0.34730433 |
53 | ERN1 | 0.32261998 |
54 | MST1R | 0.31997105 |
55 | TYK2 | 0.29310209 |
56 | MAP3K5 | 0.28879913 |
57 | TGFBR2 | 0.28826393 |
58 | SGK1 | 0.27583875 |
59 | SGK2 | 0.27484631 |
60 | PRKACB | 0.27175126 |
61 | LRRK2 | 0.27005679 |
62 | PKN1 | 0.26793876 |
63 | RPS6KB1 | 0.26639926 |
64 | INSRR | 0.26604342 |
65 | MAPK13 | 0.26540058 |
66 | MAP3K10 | 0.25617060 |
67 | LATS2 | 0.25557342 |
68 | LIMK1 | 0.25343908 |
69 | PRKD1 | 0.24136948 |
70 | TIE1 | 0.23229748 |
71 | PRKG1 | 0.22195488 |
72 | RPS6KA3 | 0.20866785 |
73 | PRPF4B | 0.20623861 |
74 | ROCK1 | 0.20324631 |
75 | CDK19 | 0.20053487 |
76 | MAPK7 | 0.19989412 |
77 | MAPK4 | 0.19876662 |
78 | PRKACA | 0.19712759 |
79 | DAPK2 | 0.19593212 |
80 | PDK1 | 0.16589132 |
81 | NME2 | 0.15951628 |
82 | ARAF | 0.15813614 |
83 | PDPK1 | 0.15000351 |
84 | MARK2 | 0.14891080 |
85 | MARK3 | 0.14755537 |
86 | RPS6KA1 | 0.13759252 |
87 | DYRK1B | 0.12702717 |
88 | MAP2K1 | 0.12633340 |
89 | RPS6KL1 | 0.12498397 |
90 | RPS6KC1 | 0.12498397 |
91 | ZAP70 | 0.12435363 |
92 | MOS | 0.11809365 |
93 | KSR2 | 0.11717925 |
94 | LATS1 | 0.11606632 |
95 | JAK2 | 0.10663905 |
96 | RPS6KA6 | 0.09491922 |
97 | SGK494 | 0.08635658 |
98 | SGK223 | 0.08635658 |
99 | CAMK1G | 0.08547115 |
100 | RPS6KA2 | 0.08385297 |
101 | RAF1 | 0.08291036 |
102 | CAMK2D | 0.08154957 |
103 | BRAF | 0.07322081 |
104 | TNK2 | 0.06700840 |
105 | PRKACG | 0.06292025 |
106 | FLT3 | 0.06049360 |
107 | RPS6KB2 | 0.04907632 |
108 | FER | 0.04846323 |
109 | STK11 | 0.03972046 |
110 | PAK6 | 0.03538802 |
111 | KSR1 | 0.03194504 |
112 | ROCK2 | 0.02515676 |
113 | MTOR | 0.02362537 |
114 | GSK3B | 0.02135003 |
115 | GRK7 | 0.02006929 |
116 | CSNK1D | 0.01917294 |
117 | MAPK3 | 0.01914387 |
118 | MAP2K2 | 0.01797091 |
119 | MAPK9 | 0.01226938 |
120 | FGFR1 | 0.00855577 |
121 | MAP3K9 | 0.00839291 |
122 | MAPK10 | 0.00344758 |
123 | FGFR3 | 0.00148013 |
124 | PTK2B | -0.0295413 |
125 | ICK | -0.0294630 |
126 | MAPKAPK2 | -0.0241713 |
127 | CAMK2A | -0.0238191 |
128 | DYRK3 | -0.0229362 |
129 | SGK3 | -0.0124080 |
130 | MAPK8 | -0.0001191 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.41757464 |
2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.20462621 |
3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.71438745 |
4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.56870541 |
5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.42855948 |
6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.37813888 |
7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.87757799 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.60858349 |
9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.28946270 |
10 | Circadian rhythm_Homo sapiens_hsa04710 | 2.25853496 |
11 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.25101502 |
12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.20020731 |
13 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.11981121 |
14 | Insulin resistance_Homo sapiens_hsa04931 | 2.09573528 |
15 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.06752229 |
16 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.00256836 |
17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.96126227 |
18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.82085139 |
19 | Galactose metabolism_Homo sapiens_hsa00052 | 1.81509656 |
20 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.79643572 |
21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.78590139 |
22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.76449272 |
23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.73500550 |
24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64622914 |
25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63665144 |
26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.60993275 |
27 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.57661937 |
28 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.57310822 |
29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47761871 |
30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37363317 |
31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.34772958 |
32 | Tight junction_Homo sapiens_hsa04530 | 1.19907860 |
33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.17082032 |
34 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.16141430 |
35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.15578054 |
36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.15072378 |
37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11333506 |
38 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04235282 |
39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02842972 |
40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00938512 |
41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00051198 |
42 | Focal adhesion_Homo sapiens_hsa04510 | 0.95781835 |
43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95315346 |
44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.90018686 |
45 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88229230 |
46 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86957326 |
47 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85967418 |
48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.83669660 |
49 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83498469 |
50 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.80217865 |
51 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75206603 |
52 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68174294 |
53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67764402 |
54 | Renin secretion_Homo sapiens_hsa04924 | 0.64288993 |
55 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61456106 |
56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60260212 |
57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59987169 |
58 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59211094 |
59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58847230 |
60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54652836 |
61 | Platelet activation_Homo sapiens_hsa04611 | 0.53439722 |
62 | Amoebiasis_Homo sapiens_hsa05146 | 0.53306127 |
63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48077023 |
64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45414352 |
65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43281305 |
66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42817175 |
67 | Circadian entrainment_Homo sapiens_hsa04713 | 0.40067392 |
68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37810733 |
69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37312487 |
70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35570339 |
71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34445228 |
72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34358282 |
73 | Salivary secretion_Homo sapiens_hsa04970 | 0.33156539 |
74 | Insulin secretion_Homo sapiens_hsa04911 | 0.32925995 |
75 | Adherens junction_Homo sapiens_hsa04520 | 0.32862080 |
76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31228839 |
77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29582754 |
78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.27359183 |
79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.26871435 |
80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.26797114 |
81 | Purine metabolism_Homo sapiens_hsa00230 | 0.26070127 |
82 | Peroxisome_Homo sapiens_hsa04146 | 0.25347129 |
83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25123190 |
84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25017981 |
85 | ABC transporters_Homo sapiens_hsa02010 | 0.24780081 |
86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22154137 |
87 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.21748210 |
88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.21291683 |
89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19882996 |
90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19162005 |
91 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.19012303 |
92 | Glioma_Homo sapiens_hsa05214 | 0.18109007 |
93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17289128 |
94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.16522423 |
95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.16134419 |
96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.15323064 |
97 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.14135528 |
98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.13860578 |
99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.13689868 |
100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.12989937 |
101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.11996212 |
102 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.11667499 |
103 | Long-term depression_Homo sapiens_hsa04730 | 0.11118384 |
104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.10967316 |
105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.10509280 |
106 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.09969705 |
107 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.09377181 |
108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.08908982 |
109 | Olfactory transduction_Homo sapiens_hsa04740 | 0.08109801 |
110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.07133306 |
111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.06148288 |
112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.06141435 |
113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.05960080 |
114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.05946487 |
115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.04857249 |
116 | Melanogenesis_Homo sapiens_hsa04916 | 0.04224901 |
117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.04109369 |
118 | Lysine degradation_Homo sapiens_hsa00310 | 0.03792000 |
119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.02938501 |
120 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.02290637 |
121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.01684362 |